Rang	Name	Position
1	Prof. Niels C. Riedemann M.D., Ph.D.	Co-Founder, CEO & Executive Director
2	Prof. Renfeng Guo M.D.	Co-Founder, Chief Scientific Officer & Executive Director
3	Dr. Thomas Taapken Ph.D.	Chief Financial Officer
4	Ms. Derval O'Carroll	Senior VP and Global Head of Regulatory Affairs & Compliance
5	Mr. Jan Medina CFA	Head of Investor Relations & VP
6	Mr. Christian Schmid	VP and Head of Legal Affairs & General Counsel
7	Dr. Maria Habel PH.D.	VP, Head of Preclinical R&D and QC
8	Mr. Kofi Boaten	VP and Head of Supply Quality & Clinical Trial Supplies
9	Mr. Peter Hurt Ph.D.	Senior Director and Head of Drug Safety & Pharmacovigiliance
10	Mr. Daniel Vetter	Senior Director & Head of IT

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Suvretta Capital Management, LLC	0,00%	0,00 Mio. USD
2	683 Capital Management LLC	0,00%	0,00 Mio. USD
3	Bank of America Corp	0,00%	0,00 Mio. USD
4	Eversept Partners, LP	0,00%	0,00 Mio. USD
5	Morgan Stanley - Brokerage Accounts	0,00%	0,00 Mio. USD
6	Marshall Wace Asset Management Ltd	0,00%	0,00 Mio. USD
7	Squarepoint Ops LLC	0,00%	0,00 Mio. USD
8	T3 Companies, LLC	0,00%	0,00 Mio. USD
9	Two Sigma Investments LLC	0,00%	0,00 Mio. USD
10	DCF Advisers, LLC	0,00%	0,00 Mio. USD
11	ADAR1 Capital Management LLC	0,00%	0,00 Mio. USD
12	GSA Capital Partners LLP	0,00%	0,00 Mio. USD
13	Kestra Advisory Services, LLC	0,00%	0,00 Mio. USD
14	XTX Topco Ltd	0,00%	0,00 Mio. USD
15	Susquehanna International Group, LLP	0,00%	0,00 Mio. USD
16	Insigneo Advisory Services LLC	0,00%	0,00 Mio. USD
17	Geode Capital Management, LLC	0,00%	0,00 Mio. USD
18	UBS Group AG	0,00%	0,00 Mio. USD
19	Citadel Advisors Llc	0,00%	0,00 Mio. USD
20	HRT FINANCIAL LLC	0,00%	0,00 Mio. USD